Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Surgery|February 19, 2021
Safety and Efficacy of Pancreaticoduodenectomy in OctogenariansYeqian Huang, Ramesh Damodaran Prabha, Terence C Chua, et al.
Pancreas|July 14, 2020
Routine Early 68Ga-DOTATATE Positron Emission Tomography Has Low Yield After Resection of Appendiceal Neuroendocrine NeoplasmsDavid L Chan, Jeremy Hoang, Paul J Roach, et al.
Journal of Medical Case Reports|October 28, 2021
Life-threatening diarrhea in neuroendocrine tumors: two case reportsEmma Gordon, David L Chan, Jennifer Arena, et al.
Journal of Clinical Medicine|July 2, 2021
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective AnalysisSarah Maloney, Malinda Itchins, Jennifer Arena, et al.
Journal of Clinical Medicine|March 11, 2023
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic CancerSarah Maloney, Nick Pavlakis, Malinda Itchins, et al.
The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.
Human Pathology|August 7, 2018
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumorsAngela Chou, Malinda Itchins, Philip R de Reuver, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 24, 2018
Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort studyChristopher B Nahm, John Turchini, Nigel Jamieson, et al.
Cancers|July 27, 2022
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic CancerChristopher B Nahm, John Turchini, Sumit Sahni, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Pageof 1